Articles tagged with Vision Disorders
Researchers at the University of Pittsburgh School of Medicine develop an experimental 'living eye drop' using naturally occurring eye bacteria to accelerate corneal wound healing. The engineered bacteria, Corynebacterium mastitidis, continuously secrete interleukin-10, a protein that regulates inflammation.
A University of Houston optometry researcher warns of the dangers of red-light laser myopia therapy for children, citing vision damage reports and the need for rigorous safety validation. The professor's quality improvement study found that two popular devices exceeded national standards for safety classifications.
A study published in Cornea reveals that aniridia not only alters corneal structure but also affects sensory nerve function, leading to a progressive decline in corneal sensitivity. In adulthood, patients experience difficulty distinguishing stimulus intensity and reduced tear production, compromising eye defense mechanisms.
A new study proposes that myopia is driven by how we use our eyes indoors, with prolonged close-up focus in low-light environments limiting retinal illumination. This mechanism could lead to a paradigm shift in understanding and controlling myopia progression and control.
Research reveals a strong association between telomere length and age-related cataract risk, with longer telomeres linked to lower cataract incidence and milder lens opacity. The study's findings position telomere length as a biological indicator of systemic aging processes and visual health.
Researchers found that patients with substance use disorder received life-saving treatments only when addiction consult services were involved. Fentanyl use was associated with dramatically worse visual outcomes, highlighting the importance of addressing underlying conditions alongside acute medical problems.
A blind patient partially recovered natural vision through electrical stimulation of the visual cortex, independent of the implant. The recovery was sustained over time and remained even after the device was removed, suggesting individual factors may have contributed to this outcome.
Researchers found metformin reduces progression of AMD by 37% in people over 55 years, a breakthrough in search for new treatments. The study used pictures from 2,000 eye screenings and adjusted for factors like age, sex, and duration of diabetes.
Researchers used MRI analysis to measure glymphatic system activity, finding changes related to IIH stage and pressure levels. The findings suggest a noninvasive test could diagnose IIH more reliably, improving treatment options for patients with symptoms including headaches and vision loss.
A WVU research team is working to restore vision in people with inherited blindness due to genetic mutations in the Prominin1 gene. The team has observed encouraging early results using a mouse model and plans to investigate the therapy's effectiveness beyond initial restoration.
A new study estimates that over 1.6 million people in the UK will be living with glaucoma by 2060, with nearly 50% higher prevalence than previous estimates. The researchers call for expanded eye health services and increased awareness campaigns to detect early cases and prevent vision loss.
A new study from Nagoya University in Japan has found that petrolatum-based eye ointments can cause MicroShunt glaucoma implants to swell and potentially rupture. The study suggests that clinicians should avoid using these ointments on patients with the implant, particularly when it is exposed outside the conjunctiva.
A new study demonstrates the effectiveness of a widely-used eye injection in managing hypotony, a rare condition characterized by abnormally low eye pressure. The treatment, which involves injecting HPMC gel, has shown promising results in restoring vision and increasing eye pressure.
A new study by Mass General Brigham researchers found that genetic variants thought to always cause inherited blindness occur in only 28% of people who carry them. The findings challenge traditional models of rare disease genetics, suggesting a need for updated understanding and potentially impacting the development of new treatments.
Philip R. Troyk, director of the Pritzker Institute of Biomedical Science and Engineering at Illinois Tech, has been elected as a Fellow of the National Academy of Inventors for his groundbreaking work on neuroprosthetic devices, including an implanted cortical visual prosthesis that provides artificial vision to individuals with profo...
A study has revealed that reticular pseudodrusen, associated with increased risk of vision loss in AMD, are driven by pathways on chromosome 10 and not by genetic risks on chromosome 1. The discovery highlights the need for novel treatment approaches for different AMD subtypes.
A new study at Rice University found that individuals with age-related macular degeneration (AMD) can accurately estimate the arrival time of an approaching vehicle using a combination of visual and auditory cues. Despite impaired central vision, participants relied on both modalities to make collision judgments.
Researchers tracked 120 older veterans taking gabapentinoids and loop diuretics, finding that only 4 doctors correctly identified the gabapentinoids as the cause of leg swelling. The study highlights the dangers of 'prescribing cascades' and emphasizes the need for regular monitoring and alternative treatment options.
A new poll suggests that more than 80% of people over 65 drive at least weekly, but less than half have made a plan for when they can no longer drive safely due to health changes. Only 6% of older drivers have discussed their driving with a healthcare provider.
A new computer modeling approach has simulated retinal development and identified key stages of cell diversification. The research paves the way for understanding retinal diseases and regenerative research using stem cells.
University of Minnesota researchers found that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical models. The strategy aims to intervene before severe damage occurs, potentially delaying or preventing vision loss for those with early signs of AMD.
A new MIT study reveals that temporarily anesthetizing the retina of the amblyopic eye can restore its neural connections and improve vision in adulthood. The treatment, which has been shown to be effective in infancy and early childhood, may have promising clinical potential for adults with amblyopia.
Researchers at Ritsumeikan University have discovered that the loss of TRPM1 ion channels sets off a cascade of changes leading to persistent oscillations in the retina. This finding illuminates the cellular basis of congenital stationary night blindness and identifies a common mechanism underlying retinal degenerative conditions.
Researchers used brain stimulation to synchronize communication between visual regions and enhance motion perception in stroke patients. The approach showed significant improvements in visual fields and real-world performance, suggesting a faster, more accessible therapy for hemianopia recovery.
Researchers will study neural mechanisms of visual perceptual learning (VPL) to generalize across the visual field, improving vision rehabilitation and AI systems. The project aims to develop a unified model of visual processing, VPL, and attention.
A study by neuroscientists found that babies born blind retain the ability to recognize faces and objects, but not small details like contours, in their brains. The research suggests that early vision loss may not hinder brain development as much as previously thought, paving the way for new visual therapies.
A clinical trial found that ivermectin can be safely given to young children weighing as little as 5 kilograms, challenging existing manufacturer restrictions. The study's results could spur progress against diseases like intestinal worms, scabies, and river blindness.
Spanish researchers at UMH have developed a new generation of visual neuroprosthesis capable of bidirectional communication with the cerebral cortex. The system uses a small external camera to capture images, which are processed electronically and converted into electrical stimulation patterns sent to the occipital cortex. Participants...
Researchers at Wayne State University are investigating how eosinophils influence corneal response to infection, focusing on microbial keratitis and potential therapeutic strategies to preserve vision. The goal is to identify new treatments that fight infection while minimizing tissue damage.
Researchers at Aalto University have developed a promising new treatment approach for dry age-related macular degeneration (AMD), which can potentially stop the disease's progression. The novel method uses heat and near-infrared light to trigger healing responses at a cellular level, strengthening protective mechanisms of affected cells.
A team of researchers has developed an artificial retina model using 3D printing technology, which closely replicates the pathological microenvironment of retinal vein occlusion. The model exhibited responses similar to those observed in clinical cases, validating its potential as a preclinical drug evaluation system.
A cohort study found that GLP-1 receptor agonist use was associated with a reduced risk of developing nonexudative AMD, but not progression to exudative AMD in individuals with nonexudative AMD. This study may inform future randomized trials evaluating the ocular effects of GLP-1RAs in nondiabetic populations.
A wireless retinal implant has been shown to restore central vision in patients with advanced age-related macular degeneration (AMD), with 81% of participants achieving clinically meaningful improvements in visual acuity. The device converted light into electrical signals, stimulating remaining retinal cells and restoring visual inform...
A recent study published in JAMA Ophthalmology found that corneas from donors with diabetes are just as effective for surgery as those without the disease. The results suggest that the number of corneas available for transplant worldwide could be significantly increased, improving outcomes for patients seeking sight-restoring transplants.
A pioneering eye device has restored reading vision to people with sight loss, allowing them to read letters, numbers, and words through a prosthetic eye. The PRIMA chip operation involves an implant paired with augmented-reality glasses, enabling patients to regain their independence and confidence.
A study of 5.4 million older Americans found that internal migrants have significantly better health outcomes than those who remain in their birth state. Those from abroad also showed a stronger health advantage when education levels were taken into account.
A study by UC Riverside researchers identifies a strong connection between demyelination and seizure activity in multiple sclerosis. The findings suggest targeted treatments could address the root cause of seizures without suppressing overall brain activity.
Researchers developed AI-powered BlinkWise glasses that track blinking patterns to assess fatigue, mental workload, and eye-related health issues. The device uses radio signals to detect minute eyelid movements with unprecedented detail, preserving privacy and using minimal power.
Researchers developed an mRNA vaccine that suppresses abnormal blood vessel growth in mouse models of age-related macular degeneration. The vaccine is as effective as current therapies and offers a convenient alternative to frequent eye injections.
A study of nearly 30,000 Chinese children found that air pollution, particularly nitrogen dioxide and fine particles, is a significant risk factor for childhood myopia. Exposure to poor air quality can cause oxidative stress and inflammation of the eye, potentially harming vision.
Exposure to lower levels of air pollutants is associated with improved vision in children, suggesting that reducing exposure could slow the progression of myopia. Children who live in areas with cleaner air have better vision, especially younger students.
Researchers are testing whether low-concentrate atropine drops can delay the onset of myopia in children. The study aims to reduce the risk of sight-threatening complications later in life by decreasing how nearsighted someone becomes.
Researchers have identified over 120 genetic signals shaping foveal development, including pathways involved in vitamin A metabolism and retinal cell fate. The study provides the first comprehensive genetic dissection of human foveal pit architecture, revealing new insights into childhood visual disorders.
A recent study has found that people with psoriasis are at a significantly higher risk of developing AMD, including both exudative and non-exudative forms. The study suggests that biologic therapies may offer protective benefits for individuals with psoriasis.
A new study shows that laser treatment, PRK, is as safe and effective in treating myopia in older teenagers (17-18 years) as it is in adults. The procedure achieved excellent results with around 64% of teenagers' eyes achieving 20/20 vision.
A study found that more than half of the general population in the USA and Europe experience dry eyes, with only 20% of European patients and 17% of US patients receiving a diagnosis. The delay in seeking treatment is concerning, as early intervention can prevent inflammation and worsening symptoms.
Researchers developed a new treatment using specially formulated eye drops that improved near vision for patients with presbyopia. The study found that the majority of patients could read extra lines on the Jaeger chart after using the eye drops, and improvements were sustained for up to two years.
Researchers used AI to assess images of patients' eyes and predict those who needed prompt treatment, successfully sorting up to 90% of patients. The study's findings could lead to earlier treatment and reduced unnecessary monitoring for patients with keratoconus.
Two new studies show that cataract surgery on both eyes can be safe and effective for most patients to perform immediately after surgery, with high rates of independence and minimal need for assistance. Patients receiving multifocal lenses achieved the best visual outcomes, with over 85% achieving 20/20 vision or better.
A team of researchers has received funding to study the PRPH2 gene, crucial for normal vision, but when mutated causes a range of retinal diseases leading to blindness. They aim to uncover the underlying mechanisms of PRPH2-associated pathology to develop effective therapies.
Researchers at Seoul National University of Science and Technology developed a microelectrode with three-dimensional carbon nanotubes that efficiently conduct electricity while being soft like tissue. The arrays demonstrated stable insertion in brain tissues, precise recording of visual responses, and reduced inflammatory responses.
Researchers at Wayne State University are developing novel therapies to treat ocular chemical injuries using host-derived metabolites. The project aims to reduce inflammation, promote corneal nerve regeneration, and enhance wound healing, with potential for clinically translatable treatments that can preserve vision.
Researchers mapped fluid reservoir dynamics in scleral lens wear, finding rapid changes within the first two hours and regional asymmetry. The study emphasizes the need for comprehensive evaluation of peripheral corneal areas to ensure optimal lens fitting and ocular health.
Glaucoma is a leading cause of vision loss, with over 7.7 million people globally affected in 2020. The new microstent reduces excessive fluid buildup and intraocular pressure, supporting the eye's natural space and improving treatment efficacy. Its durable nickel-titanium alloy enables long-term safety and functionality.
Cohort study finds GLP-1 receptor agonist use associated with modestly increased risk of incident diabetic retinopathy; however, those with preexisting DR experience fewer sight-threatening complications. Regular screening and monitoring recommended for all T2D patients on GLP-1 RAs.
A new study published in JAMA Network Open reveals that patients with type 2 diabetes prescribed semaglutide or tirzepatide are at increased risk of nonarteritic anterior ischemic optic neuropathy and other optic nerve disorders. The overall risk is low, but highlights the need for close monitoring of these conditions.
Researchers have established apple snails as a system to study eye regeneration, which may hold the key for restoring vision due to damage and disease. The team discovered that the snail eye is anatomically similar to humans and can regrow itself, with genes such as pax6 playing a crucial role in development.
In a breakthrough study, researchers at the University of Rochester Medical Center found that microglia cells respond differently than neutrophils to photoreceptor damage in the retina. This discovery has high implications for treating vision loss caused by photoreceptor cell damage.
A new route of delivering gene therapy is being explored, potentially reducing invasiveness and increasing accessibility. Researchers will test a novel approach on non-human primates, aiming to expand access to office-based treatments.
Scientists have identified a potential treatment strategy for ADOA by targeting the SARM1 protein, which triggers axon degeneration in retinal ganglion cells. Deleting or disabling SARM1 preserves RGCs and maintains vision in a mouse model.